PALRIZU
Live / Applied — Third extension granted (statement of use) (as of 28 Jan 2026)
What this means for you
Not registered yet, but its 29 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98290651
- Mark type
- Stylized text
- Filed
- 29 Nov 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders
Owner
- Neumora Therapeutics, Inc., Watertown, MA, US
- Neumora Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2026 — SOU EXTENSION 3 GRANTED
- 28 Jan 2026 — SOU EXTENSION 3 FILED
- 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2025 — SOU EXTENSION 2 GRANTED
- 12 Sept 2025 — SOU EXTENSION 2 FILED
- 12 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2024 — SOU EXTENSION 1 GRANTED
- 02 Oct 2024 — SOU EXTENSION 1 FILED
- 02 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION